Dravet syndrome is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of Dravet syndrome requires individualized development, typically including multidimensional management, including drug therapy, rehabilitation interventions, and regular follow-up visits. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, with timely adjustment according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Dravet syndrome. The platform serves a team of experts at home and abroad in the field of neural systems related to the China International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.